Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Natures Sunshine Products (NATR) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Natures Sunshine Products (NATR) over the last 16 years, with Q3 2025 value amounting to $95.6 million.

  • Natures Sunshine Products' Cash & Equivalents rose 2140.93% to $95.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $95.6 million, marking a year-over-year increase of 2140.93%. This contributed to the annual value of $84.7 million for FY2024, which is 282.5% up from last year.
  • Per Natures Sunshine Products' latest filing, its Cash & Equivalents stood at $95.6 million for Q3 2025, which was up 2140.93% from $81.3 million recorded in Q2 2025.
  • Natures Sunshine Products' 5-year Cash & Equivalents high stood at $95.6 million for Q3 2025, and its period low was $56.3 million during Q2 2022.
  • Its 5-year average for Cash & Equivalents is $75.5 million, with a median of $76.0 million in 2023.
  • Per our database at Business Quant, Natures Sunshine Products' Cash & Equivalents surged by 4226.05% in 2021 and then plummeted by 3034.44% in 2022.
  • Over the past 5 years, Natures Sunshine Products' Cash & Equivalents (Quarter) stood at $86.2 million in 2021, then plummeted by 30.34% to $60.0 million in 2022, then soared by 37.22% to $82.4 million in 2023, then grew by 2.82% to $84.7 million in 2024, then grew by 12.81% to $95.6 million in 2025.
  • Its Cash & Equivalents was $95.6 million in Q3 2025, compared to $81.3 million in Q2 2025 and $86.5 million in Q1 2025.